OCUL
USDOcular Therapeutix Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$11.200
Haut
$11.355
Bas
$10.400
Volume
1.84M
Fondamentaux de l'Entreprise
Capitalisation Boursière
2.3B
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
2.72M
Bourse
NGM
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
Ocular Therapeutix™ Reports Third Quarter 2025 Financial Results and Business Highlights
Recent Investor Day highlighted how AXPAXLI™ is positioned to redefine retina based on potential superiority label, market expansion, and immediate adoptability Announced today that SOL-R achieved target
TD Cowen Maintains Buy on Ocular Therapeutix, Raises Price Target to $20
TD Cowen analyst Tara Bancroft maintains Ocular Therapeutix with a Buy and raises the price target from $14 to $20.
Ocular Therapeutix™ to Report Third Quarter 2025 Financial Results on November 4, 2025
BEDFORD, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, "Ocular")), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that it plans
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.